Recipharm Israel News and Activities

Recipharm Israel is owned by Recipharm. Recipharm has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

Acquisition, funding and merger involving Recipharm.

• Scinai Immunotherapeutics has acquired Recipharm Israel (posted on February 18 2026).

View the org chart displaying its 3 main executives

Most searched biographies at Recipharm Israel

• Sylvia Kachalsky, General Manager
• Helen Domeshek, Business Development Manager
• Alexander Senderikhin, Head of Development

Popular executive movements at Recipharm

• Neil Jones has joined the company as Chief Commercial Officer  (posted on September 9 2025).

Create your alert
to follow the executive moves at Recipharm Israel.

Recipharm has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Recipharm Israel

Social media about Recipharm Israel

• Recipharm Israel on Wikipedia, Google News & Yahoo Finance
• Recipharm Israel on LinkedIn, X (Twitter) & YouTube